| |
| |
|
| Insider
Information: |
Olson William C |
| Relationship: |
Senior VP, Research an... |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
45,544 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$186,730 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
45,544 |
|
|
| Total
Value |
$186,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Senior VP, Research an... |
2012-06-20 |
45,544 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
VP, Research and DevelopmentOf |
• – – |
2005-06-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,761 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2005-07-01 |
4 |
A |
$0.00 |
$2,728 |
D/D |
4,659 |
17,770 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
23,879 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,333 |
32,525 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
36,622 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
45,992 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2010-01-04 |
4 |
OE |
$3.78 |
$11,307 |
D/D |
2,989 |
40,147 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2006-02-06 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
20,135 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2006-02-21 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
20,135 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2006-03-20 |
4 |
OE |
$4.00 |
$8,000 |
D/D |
2,000 |
20,135 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2006-05-04 |
4 |
OE |
$4.00 |
$40,428 |
D/D |
10,107 |
28,310 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2006-05-05 |
4 |
OE |
$4.00 |
$15,572 |
D/D |
3,893 |
22,096 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-12-03 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
28,756 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-10-01 |
4 |
OE |
$4.26 |
$10,788 |
D/D |
2,533 |
39,215 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2010-10-01 |
4 |
OE |
$4.32 |
$29,859 |
D/D |
6,915 |
53,125 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2010-07-01 |
4 |
OE |
$4.44 |
$11,282 |
D/D |
2,541 |
38,274 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2010-01-04 |
4 |
D |
$4.45 |
$12,104 |
D/D |
(2,720) |
37,427 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2010-04-01 |
4 |
OE |
$4.56 |
$11,344 |
D/D |
2,490 |
40,124 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-06-23 |
4 |
AS |
$4.73 |
$11,815 |
D/D |
(2,500) |
35,677 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2011-01-03 |
4 |
OE |
$4.83 |
$12,466 |
D/D |
2,582 |
49,655 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-10-01 |
4 |
D |
$5.01 |
$11,548 |
D/D |
(2,305) |
36,910 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2011-04-01 |
4 |
OE |
$5.05 |
$11,984 |
D/D |
2,373 |
49,921 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2010-10-01 |
4 |
D |
$5.08 |
$31,770 |
D/D |
(6,254) |
46,871 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP, Research & Development |
• – – |
2010-07-01 |
4 |
D |
$5.35 |
$12,209 |
D/D |
(2,282) |
35,992 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2010-04-01 |
4 |
D |
$5.36 |
$12,146 |
D/D |
(2,266) |
37,858 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
